Loren Keith Henry, Ph.D
Affiliations: | 1994-2000 | Cellular, Molecular and Developmental Biology | University of Tennessee, Knoxville, Knoxville, TN, United States |
| 2000-2008 | Pharmacology | Vanderbilt University Medical Center, Nashville, TN, United States | |
| 2008- | Basic Sciences | The University of North Dakota, Grand Forks, ND, United States |
Area:
monoamine neurotransmitter transporters, serotonin, dopamine, drugs of abuse, epigeneticsWebsite:
http://henrylab.orgGoogle:
"Loren Henry"Mean distance: 16.19 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Randy D. Blakely | post-doc | 2000-2008 | Vanderbilt University Medical Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kumar V, Yarravarapu N, Lapinsky DJ, et al. (2015) Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram. Journal of Medicinal Chemistry |
| Bowton E, Saunders C, Reddy IA, et al. (2014) SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Translational Psychiatry. 4: e464 |
| Dahal RA, Pramod AB, Sharma B, et al. (2014) Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site. The Journal of Biological Chemistry. 289: 29712-27 |
| Felts B, Pramod AB, Sandtner W, et al. (2014) The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport. The Journal of Biological Chemistry. 289: 1825-40 |
| Gaffaney JD, Shetty M, Felts B, et al. (2014) Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge. Neurochemistry International. 73: 16-26 |
| Beckman ML, Pramod AB, Perley D, et al. (2014) Stereoselective inhibition of serotonin transporters by antimalarial compounds. Neurochemistry International. 73: 98-106 |
| Pramod AB, Foster J, Carvelli L, et al. (2013) SLC6 transporters: structure, function, regulation, disease association and therapeutics. Molecular Aspects of Medicine. 34: 197-219 |
| Henry LK, Iwamoto H, Field JR, et al. (2011) A conserved asparagine residue in transmembrane segment 1 (TM1) of serotonin transporter dictates chloride-coupled neurotransmitter transport. The Journal of Biological Chemistry. 286: 30823-36 |
| Thompson BJ, Jessen T, Henry LK, et al. (2011) Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proceedings of the National Academy of Sciences of the United States of America. 108: 3785-90 |
| Thompson BJ, Jessen T, Henry LK, et al. (2011) Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter (Proceedings of the National Academy of Sciences of the United States of America (2011) 108, 9, (3785-3790) DOI: 10.1073/pnas.1011920108) Proceedings of the National Academy of Sciences of the United States of America. 108: 6689 |